LinkedIn Email

888 Boylston Street, Suite 1111
Boston, MA 02199

All Rights Reserved. Omega Fund Management, LLC 2021

Site by Impression Studio

Updates &
Announcements

View all press

February 12, 2021

2021: The Rise of the Variants – TimmermanReport.com

2021: The Rise of the Variants – TimmermanReport.com

January 14, 2021

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

January 7, 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

January 7, 2021

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

January 7, 2021

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

January 6, 2021

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

January 5, 2021

Ikena Oncology Closes $120 Million Series B Financing Led by Omega Funds

Ikena Oncology Closes $120 Million Series B Financing Led by Omega Funds

December 19, 2020

There Is Light at the End of the Tunnel, Yes. But it’s a Long Tunnel – TimmermanReport.com

There Is Light at the End of the Tunnel, Yes. But it’s a Long Tunnel – TimmermanReport.com

December 15, 2020

Lilly Announces Agreement to Acquire Prevail Therapeutics

Lilly Announces Agreement to Acquire Prevail Therapeutics

December 8, 2020

Syros Closes $90.5 Million Strategic Financing

Syros Closes $90.5 Million Strategic Financing

Our Impact
Investing in tranformative, not incremental, innovation

Companies

Omega Funds portfolio companies since inception, with >$1m cost. Past performance is not indicative of future returns.

View Compete Portfolio List

Achaogen

Developing and commercializing innovative antibacterial treatments

Achaogen

Acrux

Developing and commercializing generic and specialty topical pharmaceuticals

Acrux

Adagio Therapeutics

Developing best-in-class antibodies that can broadly neutralize SARS-CoV-2 and additional pre-emergent coronaviruses

Adagio Therapeutics

Alpine Immune

Creating protein-based multispecific immunotherapies

Alpine Immune

Amunix

Developing prodrugs that can safely harness the immune system

Amunix

Anaconda Biomed

Developing next generation thrombectomy systems for the treatment of ischemic stroke

Anaconda Biomed

Andrew Alliance

A complete software ecosystem for manual pipetting, light automation and full automation

Andrew Alliance

Aquarius

Designs, manufactures and customizes biological wastewater treatment solutions

Aquarius

Arcutis

Developing and commercializing treatments for immune-mediated dermatological diseases

Arcutis

Ardana

Focused on in-licensing and co-marketing of reproductive health products

Ardana

Arpida

Focused on treating severe bacterial infections

Arpida

Arrakis Therapeutics

Building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines

Arrakis Therapeutics

Atea

Focused on the discovery of oral direct-acting antiviral therapies

Atea

Attenua

Developing novel medicines for chronic respiratory disorders

Attenua

Beam Therapeutics

Pioneering the use of base editing for life-long cures to patients suffering from serious diseases

Beam Therapeutics

Bioinvent International

Focused on clinical development of antibody drugs for immunotherapy against cancer.

Bioinvent International

BioSilta

Develops innovative, reagent-based bacterial and yeast expression culture systems

BioSilta

BioVex

Developer of biologics for the treatment of cancer and prevention of infectious diseases.

BioVex

Checkmate

Developing its proprietary technology to harness the power of the immune system to combat cancer.

Checkmate

Chord

Developing new treatments for rare, life-threatening and severely disabling neurological diseases.

Chord

Cidara Therapeutics

Focused on the discovery, development, and commercialization of novel anti-infectives

Cidara Therapeutics

CropDesign

Provider of agronomic traits for the commercial seed markets in Belgium and internationally.

CropDesign

Cymabay Therapeutics

Developer of drugs that are intended to treat serious metabolic disorders.

Cymabay Therapeutics

DBV Technologies

Provider of therapy for food and pediatric allergy patients.

DBV Technologies

Develogen

Develops therapies for metabolic disorders based on model organisms and stem cell expertise.

Develogen

Dicerna

Involved in the discovery and development of innovative treatments for rare inherited diseases

Dicerna

EDITAS Medicine

Treating patients with genetically defined diseases by correcting disease-causing genes.

EDITAS Medicine

Egalet

Focused on the commercialization and development of abuse-resistant opioid formulations.

Egalet

Elbion/Biotie

Developing and commercializing neurology therapies

Elbion/Biotie

Elixir

Developing treatments targeting metabolic diseases and disorders

Elixir

Enanta

Developing small molecule drugs for viral infections and liver diseases

Enanta

Endeavor BioMedicines

Developing new treatments targeting the underlying causes of pulmonary fibrosis

Endeavor BioMedicines

Epigenomics

Molecular diagnostics company focused on blood testing for the early detection of cancer

Epigenomics

ESSA

Focused on developing novel therapies for the treatment of prostate cancer

ESSA

Etherna

Developer of targeted mRNA therapies for the human immune system.

Etherna

Everimmune

Devoted to treating cancer with live biotherapeutic products

Everimmune

Evotec

A drug discovery partnership company providing drug discovery solutions

Evotec

Exenta

Supply chain software provider

Exenta

ExonHit

Provider of specialty in vitro diagnostics and life-science solutions.

ExonHit

FibroGen

Developing and commercializing a treatment for anemia associated with chronic kidney disease

FibroGen

FirstWave

Selectively targeting disease-causing immune cells to treat inflammatory diseases

FirstWave

FoRx Therapeutics

Drugging key molecular targets involved in DNA replication stress, towards the development of targeted anticancer drugs

FoRx Therapeutics

Gelsight

Developer of a sensor technology

Gelsight

Gossamer Bio

Focused on therapeutics in the disease areas of immunology, inflammation, and oncology.

Gossamer Bio

Hybrigenics

Focused on research and development of new targets and therapies against cancer.

Hybrigenics

Hydrocision

Developer of fluid-jet based surgical tools for the spine market.

Hydrocision

IFM Therapeutics

Developer of small molecules that modulate novel targets in the innate immune system.

IFM Therapeutics

Ikena Oncology

Developing breakthrough targeted oncology and immunometabolism therapies for difficult to treat cancers

Ikena Oncology

Imago BioSciences

Developing pioneering medicines for the treatment of myeloproliferative diseases

Imago BioSciences

Immunic Therapeutics

Developing selective therapies aimed at treating chronic inflammatory and autoimmune diseases

Immunic Therapeutics

ImpactRx

Provider of high-value data, analytics, and technology services

ImpactRx

Intarcia Therapeutics

Developing innovative therapies utilizing a proprietary delivery system

Intarcia Therapeutics

Intercytex Group

Provider of regenerative medicine product and services

Intercytex Group

JenaValve Technology

Developer of transcatheter heart valve replacement systems

JenaValve Technology

Jerini

Developer and marketer of peptide-based drugs.

Jerini

Jounce Therapeutics

Developing therapies that enable the immune system to attack tumors

Jounce Therapeutics

Juno Therapeutics

Focused on developing cellular immunotherapies for the treatment of cancer.

Juno Therapeutics

Kezar Life Sciences

Developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.

Kezar Life Sciences

Kronos Bio

Focused on the discovery and development of novel cancer therapeutics.

Kronos Bio

Kuros Biosciences

Focused on the development of a new class of bio-pharmaceutical products

Kuros Biosciences

Lexeo Therapeutics

Focused on discovering and developing gene therapy treatments and cures to some of today's most devastating diseases

Lexeo Therapeutics

Median Technologies

Provider of medical imaging products and services

Median Technologies

Micromet

Developer of proprietary antibodies to treat cancer, inflammation and autoimmune diseases.

Micromet

Middlebrook

Manufacturer of anti-infective drugs.

Middlebrook

Momenta

Focused on the characterization and development of innovative drugs in autoimmune diseases.

Momenta

Morphic Therapeutic

Focused on developing a pipeline of oral small-molecule integrin therapeutics.

Morphic Therapeutic

Nabriva

Engaged in the research and development of novel anti-infective agents

Nabriva

Neurotech

Developer of a novel therapy system designed in the treatment of a broad array of eye diseases.

Neurotech

Neurovision

Developer of retinal imaging technology intended to offer early detection of Alzheimer's disease.

Neurovision

Newron

Focused on the development of therapies for patients with diseases of the nervous system.

Newron

Newsummit Biopharma

Provider of drug development process applications.

Newsummit Biopharma

NitroMed

Developer of novel pharmaceuticals products for the treatment of heart failure.

NitroMed

NsGene

Developer of biological products designed to provide treatment of neurological diseases.

NsGene

Nuvation Bio

Developing next generation therapies that will target the foremost unmet needs in oncology

Nuvation Bio

ObsEva

Focused on therapeutics for serious conditions that compromise a woman's reproductive health

ObsEva

OnPath

Provides connectivity and monitoring solutions for high-performance networks

OnPath

Orqis

Developing devices for the treatment of congestive heart failure

Orqis

Oxagen

Developer of small molecule drugs designed to treat inflammatory and respiratory diseases.

Oxagen

Paion

Developing and commercializing medical innovations for procedural sedation and anesthesia

Paion

Paratek

Development and commercialization of novel therapies for life-threatening diseases

Paratek

Phoqus

Development and commercialization of drugs using the electrostatic deposition technology

Phoqus

Pieris

Engaged in the discovery and development of Anticalin class of biotherapeutics.

Pieris

Precisense

Focused on continuous glucose monitoring (CGM) technology

Precisense

Prevail Therapeutics

Developing and commercializing gene therapies for patients with neurodegenerative diseases.

Prevail Therapeutics

Proteon Therapeutics

Engaged in the development of novel pharmaceuticals for renal and vascular disease.

Proteon Therapeutics

Replimune

Developing drugs to maximally activate the immune system against solid tumors.

Replimune

Rib-X

Develops differentiated antibiotics for acute care and community settings.

Rib-X

Sana

Developer of engineered cells intended to be used as medicine for patients.

Sana

Santaris Pharma

Developer of ribonucleic acid (RNA) targeted therapies.

Santaris Pharma

Scibase Holdings

Develops and sells cancer diagnostics instruments.

Scibase Holdings

Scorpion Therapeutics

Pioneering the discovery and development of small molecule, tumor-agnostic therapies

Scorpion Therapeutics

Senti Biosciences

Developer of novel therapeutics designed to deliver more precise treatments.

Senti Biosciences

Sienna

Developing first-in-class, targeted, topical products in medical dermatology and aesthetics.

Sienna

Sosei Group

Utilizes its peptide platform technologies to develop treatments for a wide range of illnesses.

Sosei Group

Spherics

Developing and manufacturing oral pharmaceutical products

Spherics

Spinevision

Developing and marketing of implants and instrumentation for spinal treatment

Spinevision

Spruce BioSciences

Developing pioneering medicines for the treatment of myeloproliferative diseases

Spruce BioSciences

Syros

Redefining the power of small molecules to control the expression of genes

Syros

Telesta Therapeutics

Developing transformational therapeutics for the treatment of serious human diseases

Telesta Therapeutics

Translate Bio

Developing medicines to treat diseases caused by protein or gene dysfunction.

Translate Bio

Trevi Therapeutics

Development and commercialization of nalbuphine ER to treat serious neurological conditions.

Trevi Therapeutics

Trident

Develops immunomodulatory drugs for the treatment of autoimmune disorders

Trident

Visterra

Developing innovative antibody-based therapies for the treatment of kidney diseases

Visterra

Vivostat

Developer and manufacturer of fibrin based hemostasis and surgical sealant products.

Vivostat

W4

Provider of Internet-based workflow software solutions

W4

Xtuit

Developing micro-environment activated therapeutics.

Xtuit

Load More